ConserV Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- ConserV Bioscience's estimated annual revenue is currently $310k per year.
- ConserV Bioscience's estimated revenue per employee is $77,500
Employee Data
- ConserV Bioscience has 4 Employees.
- ConserV Bioscience grew their employee count by 0% last year.
ConserV Bioscience's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
ConserV Bioscience Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 4 | 0% | N/A | N/A |
What Is ConserV Bioscience?
ConserV is a late-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. We have a pipeline of eight vaccines in pre-clinical and clinical development including broad-spectrum influenza*, broad-spectrum coronavirus, mosquito-borne diseases*, HIV, Hepatitis C, Hepatitis B, Rotavirus and Chagas. ConserV’s USP is the identification of antigens consisting of conserved regions of viral proteins containing a high number of REACTIVE T-cell epitopes with extensive HLA coverage. *Sub-licensed to Imutex Limited, a 51% owned subsidiary. hVIVO Services Limited own 49% of Imutex.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$310k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Bicester
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 18 | 6% | N/A |
#2 | $4.6M | 20 | N/A | N/A |
#3 | $3.6M | 31 | N/A | N/A |
#4 | $4.2M | 38 | 12% | $4M |
#5 | $7.4M | 38 | 3% | N/A |